(2026). In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses. Molecular Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"In Vitro and in Silico Modelling of ROS1‐positive Non‐small Cell Lung Cancer Reveals Fusion‐dependent Tyrosine Kinase Inhibitor Responses."
Molecular Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"In Vitro and in Silico Modelling of ROS1‐positive Non‐small Cell Lung Cancer Reveals Fusion‐dependent Tyrosine Kinase Inhibitor Responses."
Molecular Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.